Suresh Hedau

1.7k total citations
45 papers, 1.3k citations indexed

About

Suresh Hedau is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Suresh Hedau has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 13 papers in Surgery and 13 papers in Oncology. Recurrent topics in Suresh Hedau's work include Cervical Cancer and HPV Research (20 papers), Hepatitis B Virus Studies (5 papers) and Cancer-related Molecular Pathways (5 papers). Suresh Hedau is often cited by papers focused on Cervical Cancer and HPV Research (20 papers), Hepatitis B Virus Studies (5 papers) and Cancer-related Molecular Pathways (5 papers). Suresh Hedau collaborates with scholars based in India, United States and Saudi Arabia. Suresh Hedau's co-authors include Bhudev C. Das, Alok C. Bharti, Shirish Shukla, Sutapa Mahata, Varanasi Gopalkrishna, Neeraj Jain, Showket Hussain, Suresh Bhambhani, Sanjay Katiyar and Seemi Farhat Basir and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and CHEST Journal.

In The Last Decade

Suresh Hedau

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suresh Hedau India 23 609 424 387 329 202 45 1.3k
Jeffrey Killeen United States 21 940 1.5× 319 0.8× 381 1.0× 674 2.0× 182 0.9× 53 1.8k
Showket Hussain India 24 605 1.0× 548 1.3× 426 1.1× 247 0.8× 318 1.6× 84 1.5k
Soon Beom Kang South Korea 23 578 0.9× 498 1.2× 315 0.8× 380 1.2× 278 1.4× 77 1.8k
Hugo Sousa Portugal 28 529 0.9× 527 1.2× 653 1.7× 222 0.7× 426 2.1× 83 1.8k
S Dattagupta India 21 300 0.5× 441 1.0× 221 0.6× 378 1.1× 86 0.4× 48 1.2k
Laura Giuliani Italy 20 297 0.5× 375 0.9× 277 0.7× 204 0.6× 119 0.6× 34 1.2k
Dhananjaya Saranath India 27 407 0.7× 871 2.1× 662 1.7× 264 0.8× 357 1.8× 69 2.0k
Shama Virani United States 17 242 0.4× 413 1.0× 516 1.3× 152 0.5× 228 1.1× 41 1.2k
Neeraj Jain India 16 331 0.5× 224 0.5× 182 0.5× 164 0.5× 85 0.4× 46 831
Jen‐Yang Chen Taiwan 16 215 0.4× 213 0.5× 503 1.3× 124 0.4× 128 0.6× 18 903

Countries citing papers authored by Suresh Hedau

Since Specialization
Citations

This map shows the geographic impact of Suresh Hedau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh Hedau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh Hedau more than expected).

Fields of papers citing papers by Suresh Hedau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh Hedau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh Hedau. The network helps show where Suresh Hedau may publish in the future.

Co-authorship network of co-authors of Suresh Hedau

This figure shows the co-authorship network connecting the top 25 collaborators of Suresh Hedau. A scholar is included among the top collaborators of Suresh Hedau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh Hedau. Suresh Hedau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Singh, Ragini, et al.. (2023). Role of identified proteins in the proteome profiles of CDK4/6 inhibitor-resistant breast cancer cell lines. Molecular Omics. 19(5). 404–417. 7 indexed citations
3.
Gandhi, Gauri, et al.. (2023). Comparison of HPV 16/18 Genotyping and p16/Ki67 Dual Staining for Detection of High-Grade Cervical Lesion in Patients with Low-Grade Cervical Smears. The Journal of Obstetrics and Gynecology of India. 73(3). 248–253. 2 indexed citations
4.
Hedau, Suresh, Mohit Kumar, Sonal Sharma, et al.. (2019). p16 promoter methylation, expression, and its association with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 subtype of breast carcinoma. Journal of Cancer Research and Therapeutics. 15(5). 1147–1147. 8 indexed citations
5.
Kumar, Mohit, Sonal Sharma, Navneet Kaur, et al.. (2017). BRCA1 Promoter Methylation and Expression - Associations with ER+, PR+ and HER2+ Subtypes of Breast Carcinoma. PubMed. 18(12). 3293–3299. 8 indexed citations
6.
Hedau, Suresh, et al.. (2015). Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer. Journal of Cancer Research and Therapeutics. 11(1). 158–158. 26 indexed citations
7.
Shukla, Shirish, Sutapa Mahata, Gauri Shishodia, et al.. (2014). Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer. SHILAP Revista de lepidopterología. 5 indexed citations
8.
Shukla, Shirish, Sutapa Mahata, Gauri Shishodia, et al.. (2014). Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer.. PubMed. 139(4). 531–43. 45 indexed citations
9.
Hedau, Suresh, et al.. (2013). Value of high-risk human papillomavirus 16 deoxyribonucleic acid testing with cytological entities in peri and postmenopausal women. Journal of Cytology. 30(3). 190–190. 3 indexed citations
10.
Dhillon, Varinderpal S., Mohammad Shahid, Hesham Khalil, et al.. (2012). GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients. Experimental and Therapeutic Medicine. 4(6). 1097–1103. 33 indexed citations
12.
Hedau, Suresh, Debdutta Bhattacharya, Nagarajan Muruganandam, et al.. (2011). High-risk HPV infection among the tribal and non-tribal women of the Andaman and Nicobar Islands, India. Public Health. 126(1). 67–69. 5 indexed citations
13.
Shukla, Shirish, Gauri Shishodia, Sutapa Mahata, et al.. (2010). Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection. Molecular Cancer. 9(1). 282–282. 103 indexed citations
14.
Hussain, Showket, Rashid Mir, Nazir Ahmad Dar, et al.. (2009). Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area. Molecular and Cellular Biochemistry. 332(1-2). 51–58. 38 indexed citations
15.
Hussain, Showket, Alok C. Bharti, Rashid Mir, et al.. (2009). Transcription factor AP-1 in esophageal squamous cell carcinoma: Alterations in activity and expression during Human Papillomavirus infection. BMC Cancer. 9(1). 329–329. 31 indexed citations
16.
Hedau, Suresh, et al.. (2008). Sex hormone binding globulin in breast cancer. Indian Journal of Clinical Biochemistry. 23(3). 250–254. 10 indexed citations
17.
Gupta, Ruchika, Sompal Singh, Suresh Hedau, et al.. (2006). Spindle cell carcinoma of head and neck: an immunohistochemical and molecular approach to its pathogenesis. Journal of Clinical Pathology. 60(5). 472–475. 33 indexed citations
18.
Jain, Neeraj, Vikram Singh, Suresh Hedau, et al.. (2005). Infection of Human Papillomavirus Type 18 and p53 Codon 72 Polymorphism in Lung Cancer Patients From India*. CHEST Journal. 128(6). 3999–4007. 50 indexed citations
19.
Hedau, Suresh, Neeraj Jain, Syed Akhtar Husain, et al.. (2004). Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Research and Treatment. 88(2). 177–186. 57 indexed citations
20.
Das, Dilip K., et al.. (1992). Superficial and deep‐seated tuberculous lesions: Fine‐needle aspiration cytology diagnosis of 574 cases. Diagnostic Cytopathology. 8(3). 211–215. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026